Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
This study has been terminated.
Study NCT00006054 Information provided by Office of Rare Diseases (ORD)
First Received: July 5, 2000 Last Updated: October 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Immunologic Deficiency Syndromes
Chediak-Higashi Syndrome
Common Variable Immunodeficiency
Graft Versus Host Disease
Hemophagocytic Lymphohistiocytosis
X-linked Agammaglobulinemia
Wiskott-Aldrich Syndrome
Chronic Granulomatous Disease
X-linked Hyper IgM Syndrome
Severe Combined Immunodeficiency
Additional conditions recognized in this trial
Adhesions
Agammaglobulinemia
Graft vs Host Disease
Granuloma
Granulomatous Disease, Chronic
Hyper-IgM Immunodeficiency Syndrome
Hyper-IgM Immunodeficiency Syndrome, Type 1
Leukocyte-Adhesion Deficiency Syndrome
Lymphohistiocytosis, Hemophagocytic
Lymphoproliferative Disorders
Syndrome
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Blood Platelet Disorders
Blood Protein Disorders
Disease
DNA Repair-Deficiency Disorders
Dysgammaglobulinemia
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Hematologic Diseases
Hemorrhagic Disorders
Histiocytosis
Histiocytosis, Non-Langerhans-Cell
Immune System Diseases
Immunoproliferative Disorders
Infant, Newborn, Diseases
Leukocyte Disorders
Lymphatic Diseases
Metabolic Diseases
Pathologic Processes
Phagocyte Bactericidal Dysfunction
Purpura, Thrombocytopenic
Reticuloendotheliosis
Thrombocytopenia
Interventions listed in this trial
anti-thymocyte globulin
busulfan
cyclophosphamide
cyclosporine
etoposide
methotrexate
methylprednisolone
prednisone
Additional drug interventions recognized in this trial
Antilymphocyte Serum
Cyclosporins
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Alkylating Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antiemetics
Antifungal Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Autonomic Agents
Central Nervous System Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Neuroprotective Agents
Nucleic Acid Synthesis Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Fairview University Medical Center
Back to top of Main Content
